Eradigm Consulting
Marcus Deans has extensive experience in the life sciences industry, spanning over 25 years. Marcus is currently the Managing Partner & Co-Founder at Eradigm Consulting, where Marcus leads a team of consultants providing market insight and launch readiness support for bio-pharmaceutical clients. Prior to this, Marcus held various senior positions at companies such as Deallus, Voisin Consulting Life Sciences, GfK Bridgehead, Takeda Pharmaceuticals, Eisai, Novartis Vaccines and Diagnostics, Lundbeck, and Novartis. Marcus's expertise lies in market access, competitive intelligence, and strategic marketing within the pharmaceutical sector.
This person is not in any offices
Eradigm Consulting
2 followers
Eradigm works with select biopharmaceutical companies to develop a deeper and more nuanced understanding of their markets. We focus on informing and shaping high impact strategies for your product or portfolio, whatever its stage in the clinical or commercial life-cycle. Our core expertise is built on decades of experience in the pharmaceutical sector, giving us the ability to deliver value to our clients at the intersection of three key industry dynamics: the ever increasing value imperative, shrinking sources of true competitive advantage and cutting edge therapeutic innovation. Our founding team’s experience spans more than 30 years both leading and supporting the development and commercialisation of some of the world’s most lucrative and innovative biopharmaceutical products.